A University of Missouri scientist develops a cancer “flashlight” that helps identify which patients are most likely to respond to targeted therapies. To better understand which patients may respond to targeted cancer therapies, a University of Missouri researcher is developing a new way to make tumors visible at the molecular level. In a recent study, […]Health,Cancer,Molecular Biology,Oncology,University of Missouri-Columbia#Cancer #Flashlight #Reveal #Benefits #Targeted #Treatments1768401922
